Is Vanzacato/Tizacaftor/Deuterated Ivacaftor Combination Tablets available in China? What's the price? How can it be obtained?

Up to now, Vanzacato/Tizacaftor/Deuterated ivacaftor compound tablets have not yet been launched in mainland China, so they are temporarily unavailable for purchase in hospitals or pharmacies. The drug was developed by Vertex Company. It is currently in the late clinical or overseas approval stage and is expected to be gradually launched globally in the future. Since it has not yet been approved in China, if patients need urgent treatment, they can obtain it through overseas medical treatment, international drug purchasing platforms or cross-border medical service applications. Referring to the prices of existing triple drugs similar to CF (such as Trikafta), we can initially estimate the annual treatment cost of this drug overseas. The cost may range from RMB 300,000 to RMB 400,000. The specific cost and accessibility need to be determined based on subsequent approvals and commercialization progress. Patients should pay close attention to the marketing information and consult a professional physician to evaluate the suitability of the medication.